Vaxart Shareholders Approve Stock and Equity Plan Expansion

Vaxart (VXRT) has shared an announcement.

Vaxart, Inc. stockholders have given the green light for significant expansions to the company’s equity plans and an increase in authorized shares. This move, decided at the Annual Meeting, includes a substantial rise of 15 million shares in their 2019 Equity Incentive Plan, now totaling 43.9 million shares, and a boost of 1.8 million shares to the 2022 Employee Stock Purchase Plan, bringing it to 3.6 million shares. Additionally, the company’s authorized common stock will jump from 250 million to 350 million shares, empowering Vaxart with greater flexibility for future growth and incentive strategies.

Learn more about VXRT stock on TipRanks’ Stock Analysis page.